Brainstorm Cell Therapeutics (BCLI) Return on Assets [ROA] (2009 - 2026)
Brainstorm Cell Therapeutics (BCLI) posted Return on Assets [ROA] of -1289.70% for Q2 2026, down 901.92 percentage points from -387.78% a year earlier and down 286.88 percentage points from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Brainstorm Cell Therapeutics' Return on Assets [ROA] came in at -697.48%, down 310.29 percentage points from FY2024.
- Annual Return on Assets [ROA] has declined for four consecutive years, with a five-year change of -587.83 percentage points (FY2020 to FY2025).
- In prior years, Brainstorm Cell Therapeutics' Return on Assets [ROA] was -387.19% in FY2024 (-48.47 pp), -338.72% in FY2023 (-207.13 pp), -131.58% in FY2022 (-70.64 pp) and -60.94% in FY2021 (+48.71 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q3 2011.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last five quarters, with an average year-over-year change of -250.68 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2025, with a gain of 41.01 percentage points; the weakest was Q2 2026, with a drop of 901.92 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -1002.81% (Q1 2026), -828.73% (Q4 2025) and -552.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - | -1,289.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,289.70% |
| Mar 31, 2026 | -1,002.81% |
| Dec 31, 2025 | -828.73% |
| Sep 30, 2025 | -552.36% |
| Jun 30, 2025 | -387.78% |
| Mar 31, 2025 | -455.60% |
| Dec 31, 2024 | -606.33% |
| Sep 30, 2024 | -345.30% |
| Jun 30, 2024 | -360.87% |
| Mar 31, 2024 | -493.44% |
| Dec 31, 2023 | -431.12% |
| Sep 30, 2023 | -375.01% |
| Jun 30, 2023 | -326.79% |
| Mar 31, 2023 | -307.11% |
| Dec 31, 2022 | -233.95% |
| Sep 30, 2022 | -165.54% |
| Jun 30, 2022 | -112.36% |
| Mar 31, 2022 | -84.51% |
| Dec 31, 2021 | -77.49% |
| Sep 30, 2021 | -79.06% |
API Access
Brainstorm Cell Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();